Errata: Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis The classification of AML and therapeutic options are now largely driven ...

Ezh2 loss promotes RUNX1 mutant-induced MDS Given that RUNX1 mutations are identified in ~\n30% of MDS patients harbouring EZH2 loss-of-function mutations 1,18,23, we examined how Ezh2 loss and ...

The RUNX1 gene (runt-related transcription factor 1—chromosome 21q22.3) encodes the DNA-binding, alpha subunit of the core-binding factor and is essential for normal hematopoiesis and ...